Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Muscular dystrophies are characterised by continuous cycles of degeneration and regeneration resulting in an eventual diminution of the muscle mass and extensive fibrosis. In somatic cells chromosomal telomeres shorten with each round of cell division and telomere length is considered to be a biomarker of the replicative history of the cell. We have previously shown that human myoblasts have a limited proliferative capacity, and that normal skeletal muscle has a very low level of nuclear turnover. However, in patients suffering from muscular dystrophy the satellite cells will be forced to make repeated rounds of cell division, driving the cells towards senescence. In this study we have used the telomere length to quantify the intensity of the muscle cell turnover in biopsies from dystrophic patients of different ages. Our results show that as soon as the first clinical symptoms become apparent the muscle has already undergone extensive regeneration and the rate of telomere loss is 14 times greater than that observed in controls. This confirms that the decline in regenerative capacity is due to the premature senescence of the satellite cells induced by their excessive proliferation during muscle repair.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, a 14-fold greater shortening of telomeres in DMD patients relative to healthy individuals has been reported (Decary et al., 2000).”
From Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice (2010) · cites this paper as Decary et al., 2000
In the citing paper
“Muscles from DMD patients have been reported to have shorter telomeres than healthy individuals (Decary et al., 2000; Mouly et al., 2005).”
From Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice (2010) · cites this paper as Decary et al., 2000
Citations
Cites
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975 · cited 1×
“The telomeres which are protein-DNA structures at the ends of eukaryotic chromosomes are implicated in chromosomal integrity and cellular ageing [24,25].”
Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P., Feener, C., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90504-6 · Cited by 2,411
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200 · cited 16×
“The TRFs were detected by hybridisation to a (32)P-(TTAGGG)4 probe as described by Allsopp [31].”
InfluentialTelomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650 · cited 1×
“A decrease in telomere length has been reported to occur during the in vivo ageing of various normal human tissues such as skin, intestinal mucosa, peripheral lymphocytes and skeletal muscle [23,27,28,33].”
The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
Koenig, M., Monaco, A. P., & Kunkel, L. M. (1988) · Cell · doi:10.1016/0092-8674(88)90383-2 · Cited by 1,538
Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
Ervasti, J. M., Ohlendieck, K., Kahl, S. D., Gaver, M. G., & Campbell, K. P. (1990) · Nature · doi:10.1038/345315a0 · Cited by 1,025
Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes.
Vaziri, H., Schächter, F., Uchida, I. A., Wei, L., Zhu, X., Effros, R. B., Cohen, D., & Harley, C. (1993) · PubMed · Cited by 810
ON THE CLASSIFICATION, NATURAL HISTORY AND TREATMENT OF THE MYOPATHIES
WALTON, J. N., & NATTRASS, F. J. (1954) · Brain · doi:10.1093/brain/77.2.169 · Cited by 541
Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy
Noguchi, S., McNally, E. M., Othmane, K. B., Hagiwara, Y., Mizuno, Y., Yoshida, M., Yamamoto, H., Bönnemann, C. G., Gussoni, E., Denton, P. H., et al. (1995) · Science · doi:10.1126/science.270.5237.819 · Cited by 506 · cited 1×
“The disease is linked to chromosome 13q [14] and is caused by the mutation of a gene which encodes g-sarcoglycan, a protein of the sarcoglycan complex [15].”
Self-citationDubowitz, V. (2015) · Muscular Dystrophy 1976 · doi:10.1159/000400687 · Cited by 483 · cited 6×
“Speci®c antibody binding was revealed with peroxidase S. Decary et al. / Neuromuscular Disorders 10 (2000) 113±120114 Table 1 LGMD 2C and DMD patients LGMD 2Ca DMD 3116 2872 2842 3030 2736 2710 2864 2975 2804 3255 Patients P1 P2 P3 P4 P5 P6 P7 P9 P10 P11 Age (years) 5 8 10 10 11 13 4 8 9 13 Sex F F M M F F M M M M Age…”
Influential
Research works printed but not linked: 1
- Duchenne, 1868, Recherches sur la paralysie musculaire pseudo-hypertrophique ou paralysie myo-sclérotique, Arch Gen Med, 11, 569
Cited by
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
Hill, J. M., Zalos, G., Halcox, J. P. J., Schenke, W. H., Waclawiw, M. A., Quyyumi, A. A., & Finkel, T. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022287 · Cited by 3,423
Cellular and Molecular Regulation of Muscle Regeneration
CHARGÉ, S. B. P., & RUDNICKI, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00019.2003 · Cited by 2,680
“For example, in DMD patients, where satellite cell proliferation is accentuated, telomere lengths (an indicator of the cell replicative age) are prematurely reduced compared with normal human senescence (84).”
BackgroundSarcopenia: Aging-Related Loss of Muscle Mass and Function
Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., Kirkland, J. L., & Sandri, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00061.2017 · Cited by 1,797
Myogenic satellite cells: physiology to molecular biology
Hawke, T. J., & Garry, D. J. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.2.534 · Cited by 1,644
“DMD patients (4–5 yr of age) have been shown to undergo more skeletal muscle regeneration than that measured in a total of six normal patients over 60 yr of age (46).”
MethodFunction and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle
Blake, D. J., Weir, A., Newey, S. E., & Davies, K. E. (2002) · Physiological Reviews · doi:10.1152/physrev.00028.2001 · Cited by 1,242
Metadata
- Authors
- Decary, S., Ben Hamida, C., Mouly, V., Barbet, J. P., Hentati, F., & Butler-Browne, G. S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Butler-Browne, G.S.
- Venue
- Neuromuscular Disorders
- Publisher
- Elsevier BV
- Published
- 2000-02
- Volume
- 10
- Issue
- 2
- Pages
- 113-120
- ISSN
- 0960-8966 (ISSN-L)
- OpenAlex
- W2117494436
- Cited by
- 195
- References
- 38
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 8 · 2018: 6 · 2017: 7 · 2016: 8 · 2015: 16 · 2014: 12 · 2013: 10 · 2012: 10
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Neuromuscular Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Keywords
- telomere length, muscular dystrophy, muscle regeneration, satellite cells, cellular senescence, myoblast proliferation, skeletal muscle, regenerative capacity
- MeSH terms
- Adolescent, Cell Division, Child, Child, Preschool, Female, Humans, Male, Muscular Dystrophies, Regeneration, Telomere, Cellular Senescence, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. https://app.cochat.ai/papers/10.1016/s0960-8966(99)00093-0
- The paper
- Decary, S., Ben Hamida, C., Mouly, V., Barbet, J. P., Hentati, F., & Butler-Browne, G. S. (2000). Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscular Disorders. https://doi.org/10.1016/s0960-8966(99)00093-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.